Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II study of SYHA1813 alone or in combination in unresectable locally advanced or metastatic solid tumors
CTR20244224Phase 2Terminated
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SYHA1813 in Nonhematologic neoplasms, sponsored by Shanghai Institute of Materia Medica. Started Dec 2024; status: terminated.
02
Drugs
SYHA1813
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20244224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244224.